1. Home
  2. KMDA vs CLNE Comparison

KMDA vs CLNE Comparison

Compare KMDA & CLNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KMDA
  • CLNE
  • Stock Information
  • Founded
  • KMDA 1990
  • CLNE 2001
  • Country
  • KMDA Israel
  • CLNE United States
  • Employees
  • KMDA N/A
  • CLNE N/A
  • Industry
  • KMDA Biotechnology: Pharmaceutical Preparations
  • CLNE Natural Gas Distribution
  • Sector
  • KMDA Health Care
  • CLNE Utilities
  • Exchange
  • KMDA Nasdaq
  • CLNE Nasdaq
  • Market Cap
  • KMDA 410.6M
  • CLNE 448.6M
  • IPO Year
  • KMDA N/A
  • CLNE 2007
  • Fundamental
  • Price
  • KMDA $7.32
  • CLNE $2.43
  • Analyst Decision
  • KMDA Strong Buy
  • CLNE Strong Buy
  • Analyst Count
  • KMDA 2
  • CLNE 5
  • Target Price
  • KMDA $13.00
  • CLNE $3.59
  • AVG Volume (30 Days)
  • KMDA 51.8K
  • CLNE 2.0M
  • Earning Date
  • KMDA 08-13-2025
  • CLNE 11-05-2025
  • Dividend Yield
  • KMDA 2.80%
  • CLNE N/A
  • EPS Growth
  • KMDA 27.97
  • CLNE N/A
  • EPS
  • KMDA 0.32
  • CLNE N/A
  • Revenue
  • KMDA $169,517,000.00
  • CLNE $420,579,000.00
  • Revenue This Year
  • KMDA $14.49
  • CLNE $1.46
  • Revenue Next Year
  • KMDA $10.12
  • CLNE $2.46
  • P/E Ratio
  • KMDA $21.69
  • CLNE N/A
  • Revenue Growth
  • KMDA 9.67
  • CLNE 4.08
  • 52 Week Low
  • KMDA $5.17
  • CLNE $1.30
  • 52 Week High
  • KMDA $9.16
  • CLNE $3.67
  • Technical
  • Relative Strength Index (RSI)
  • KMDA 54.83
  • CLNE 53.04
  • Support Level
  • KMDA $6.90
  • CLNE $2.35
  • Resistance Level
  • KMDA $7.43
  • CLNE $2.59
  • Average True Range (ATR)
  • KMDA 0.19
  • CLNE 0.11
  • MACD
  • KMDA 0.03
  • CLNE -0.02
  • Stochastic Oscillator
  • KMDA 80.19
  • CLNE 32.89

About KMDA Kamada Ltd.

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

About CLNE Clean Energy Fuels Corp.

Clean Energy Fuels Corp is a natural gas marketer and retailer operating in the United States and Canada. The company supplies compressed natural gas, liquefied natural gas for the United States (U.S.) and Canadian transportation markets. The majority of revenue is generated within the U.S. and mostly consists of compressed natural gas. The company operates by purchasing natural gas from local utilities; compressing, cooling, or liquefying it at company-owned plants; and selling natural gas products through company-owned or customer-owned fueling stations. The company also builds, operates, and maintains natural gas fueling stations for customers. The company's target markets include heavy-duty trucking, airports, public transit, institutional energy users, and government fleets.

Share on Social Networks: